Unimark Remedies Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ARMODAFINIL, with a corresponding US DMF Number 24945.
Remarkably, this DMF maintains an Active status since its submission on June 01, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 05, 2014, and payment made on January 22, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II